INT192287

From wiki-pain
Revision as of 16:08, 24 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 2006
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 7
Total Number 7
Disease Relevance 4.60
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (Cpd) plasma membrane (Cpd) nucleus (Cpd)
Cpd (Rattus norvegicus)
Pain Link Frequency Relevance Heat
abdominal pain 12 39.92 Quite Low
Pain 6 5.00 Very Low Very Low Very Low
depression 5 5.00 Very Low Very Low Very Low
Paracetamol 5 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
Analgesic 1 5.00 Very Low Very Low Very Low
chemokine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Renal Failure 114 100.00 Very High Very High Very High
Peritonitis 261 99.80 Very High Very High Very High
Infection 103 99.76 Very High Very High Very High
Chronic Renal Failure 10 93.68 High High
Malaria 150 92.44 High High
Anaemia 10 91.84 High High
Fever 29 85.40 High High
Body Weight 5 80.80 Quite High
Jaundice 5 78.00 Quite High
Vomiting 22 70.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
CPD modality and peritonitis
Gene_expression (modality) of CPD associated with peritonitis and renal failure
1) Confidence 0.49 Published 2006 Journal Ann Clin Microbiol Antimicrob Section Body Doc Link PMC1456984 Disease Relevance 1.59 Pain Relevance 0
This was completed by 371/442 (88%) participants who took CPD and 185/209 (88.5%) who took AL.
Gene_expression (took) of CPD
2) Confidence 0.17 Published 2009 Journal Malar J Section Body Doc Link PMC2744923 Disease Relevance 0.80 Pain Relevance 0
The ACPR rates using CPD were significantly higher than SP on day-28 but not on day-42.


Gene_expression (using) of CPD
3) Confidence 0.17 Published 2009 Journal Malar J Section Body Doc Link PMC2744923 Disease Relevance 0 Pain Relevance 0
There was no difference in the median day-7 DDS concentration between participants who took all their CPD doses and those who did not according to the MEMS™.


Gene_expression (doses) of CPD
4) Confidence 0.17 Published 2009 Journal Malar J Section Body Doc Link PMC2744923 Disease Relevance 0.08 Pain Relevance 0
ACPR rates for AL were higher than CPD or SP on days 28 and 42 (p ?
Gene_expression (higher) of CPD
5) Confidence 0.17 Published 2009 Journal Malar J Section Abstract Doc Link PMC2744923 Disease Relevance 0.21 Pain Relevance 0
The production of CPD was halted and the drug withdrawn because of concern about haemolysis.
Gene_expression (production) of CPD
6) Confidence 0.15 Published 2009 Journal Malar J Section Body Doc Link PMC2744923 Disease Relevance 0.65 Pain Relevance 0
To optimize the efficacy of antibiotic therapy, minimize patient morbidity, and hopefully preserve the function of the peritoneal membrane of patients prescribed CPD, the International Society of Peritoneal Dialysis (ISPD) published its first set of peritonitis treatment guidelines in 1983, and updated versions of these guidelines were published in 1989, 1993, 1996, 2000 and, most recently, in 2005 [7–10].
Gene_expression (prescribed) of CPD associated with peritonitis and renal failure
7) Confidence 0.05 Published 2009 Journal Pediatr Nephrol Section Body Doc Link PMC2810362 Disease Relevance 1.26 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox